Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities is a research paper published in Cancer Cell (2021). On theSindex it has a DataRank of 0. It has been cited 945 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Pfizer
Grant: 62/895,322
University of Texas System
Grant: 5 P50 CA070907
Cancer Prevention and Research Institute of Texas
Grant: RP170067
National Cancer Institute
Grant: U01 CA-213273
National Cancer Institute
Grant: R01 CA-207295
National Cancer Institute
Grant: R50-CA243698
National Cancer Institute
Grant: /NCI T32 CA009666
National Cancer Institute
Grant: U24 CA213274
National Cancer Institute
Grant: U01 CA213338
National Cancer Institute
Grant: CCSG P30-CA016672
U.S. Department of Defense
Grant: LC170171
NCI NIH HHS
Grant: R01 CA207295
NCI NIH HHS
Grant: U01 CA215845
NCI NIH HHS
Grant: P30 CA034196
NCI NIH HHS
Grant: T32 CA009666
NCI NIH HHS
Grant: P50 CA070907
NCI NIH HHS
Grant: P30 CA016672
NCI NIH HHS
Grant: U01 CA213273
NCI NIH HHS
Grant: R50 CA243698
Abell-Hanger Foundation
Institute for Tropical and Subtropical Crops, Agricultural Research Council
American Society of Clinical Oncology
National Institutes of Health
Meso Scale Diagnostics
Open Medicine Foundation
Roche
Johnson and Johnson
AbbVie
Rexanna's Foundation
AstraZeneca
International Studies Association
Khalifa Bin Zayed Al Nahyan Foundation
Bayer Fund
Boehringer Ingelheim
Spectrum Pharmaceuticals
MeSH Terms
Keywords